Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Radiation Model For Chronic Fatigue Syndrome Announced By The National CFIDS Foundation

Wednesday 22 May 2019

 

From PRNewswire:

 

Radiation symbol
 

Radiation Model for Chronic Fatigue Syndrome Announced by the National CFIDS Foundation

News provided by
National CFIDS Foundation
May 20, 2019
Copyright © 2019 PR Newswire Association LLC. All Rights Reserved. A Cision company.

NEEDHAM, Mass., May 20, 2019 /PRNewswire/ --The National CFIDS Foundation, of Needham, Massachusetts, has provided details regarding its radiation model for Chronic Fatigue Syndrome, a disease that affects millions in the United States. According to Alan Cocchetto, Medical Director for the National CFIDS Foundation, "Our latest model has now identified two key compounds, known as hydroperoxides, that appear to result from cellular injury due to radiation exposure. We believe this finding is of critical importance to the disease process that is present in our patients."

The National CFIDS Foundation identified cardiolipin hydroperoxides as the first key target that acts to disrupt proper functioning of the mitochondria, the energy factory within the cell. The second target, phosphatidylserine hydroperoxides, acts to disrupt red blood cell function resulting in altered tissue oxygenation. Basically, these two hydroperoxides act in concert as cellular toxicants to adversely affect normal cell function.

According to Gail Kansky, National CFIDS Foundation President, "As I understand it, these compounds make for the perfect storm from a disease standpoint since they adversely affect the ability of the body to function properly at many levels. We believe this to be a major tipping point in our understanding of this disease and I truly expect this to have a significant impact on our patients with regards to diagnostic testing and future therapies that will result from these efforts. As such, we are very pleased to be moving full steam ahead on this with our research groups."

 

Full article…

 


 

blog comments powered by Disqus
Previous Previous Page